The University of Sheffield announces approval of the first human trial testing regenerative cell therapy to treat sensorineural hearing loss, offering hope for restoring hearing function.
A Stanford-led phase 3 trial shows gene therapy skin grafts significantly heal chronic wounds in patients with severe epidermolysis bullosa, reducing pain and improving quality of life.
Jonathan Reid, Research and Education Lead at Deafblind UK, explores deafblindness and calls for greater awareness and support for those living with dual-sensory loss.
Around 20,000 children and young people with type 1 diabetes in England now benefit from life-changing 'artificial pancreas' technology, recommended by NICE.
A recent study from the University of Gothenburg has discovered that two existing medications can effectively treat alcohol use disorder, reducing both alcohol consumption and cravings.
Melissa Gong Mitchell, the Secretariat Lead at the AMR Industry Alliance, discusses the challenges hindering the development of urgently needed new antibiotics and the sustainable solutions needed to address these issues.
The University of Oxford has become the first UK academic institution to receive support from the European Medicines Agency's (EMA) PRIority MEdicines (PRIME) scheme for its vaccine targeting the deadly Nipah virus.
There is a beacon of hope for patients with a rare genetic disorder called Werner Syndrome as researchers unveil a groundbreaking discovery: Nicotinamide riboside, a vitamin B3 derivative, reverses premature ageing.
MS Australia is a national not-for-profit organisation dedicated to improving the lives of those affected by multiple sclerosis. Its remit includes supporting research for...
